Joseph Levitt

Dr. Joseph Levitt is an Associate Professor of Medicine in the Pulmonary, Allergy & Critical Care Medicine Division at Stanford University. He specializes in pulmonary critical care medicine and has over 10 years of clinical experience. His research focuses on early biomarker identification and clinical management of Acute Respiratory Distress Syndrome (ARDS), with a particular interest in pharmacological interventions prior to mechanical ventilation. He currently serves as Program Director of the Pulmonary and Critical Care Medicine Division at Stanford.

Education & Training:

• M.D., University of Minnesota School of Medicine (1998)
• M.S. (degree details unspecified)
• Fellowships: Stanford University (2005) and University of Chicago (2004) in Pulmonary & Critical Care Medicine

Research Interests: Dr. Levitt's work centers on improving outcomes in acute lung injury and ARDS through early intervention strategies. His lab evaluates therapies like mesenchymal stem cells, statins, and corticosteroids, while also exploring biomarkers like myeloid/lymphoid dysregulation. Key clinical trials include the START trial for ARDS and the COPPS platform trial for outpatient COVID-19 management.

Awards & Recognition: Board-certified in Pulmonary Disease and Critical Care Medicine (2024). His leadership in ARDS clinical trials has positioned him as a key contributor to critical care innovation.

Teaching & Mentorship: Oversees residency and fellowship training in pulmonary critical care, with active involvement in graduate research programs (MED 299/399).